To investigate the contribution of TG2 in the TME and potentially correlate it to tumor progression, we used two syngeneic models of ovarian cancer, each with unique metastatic properties and similar TG2 expression (Supplementary Figure S3). The gene discussed is TGM2; the disease is neoplasm.